Cerebral palsy

被引:8
作者
Barry S. Russman
机构
[1] Shriners Hospitals for Children,Pediatric Neurology
关键词
Cerebral Palsy; Botulinum Toxin; Baclofen; Muscle Tone; Gait Analysis;
D O I
10.1007/s11940-000-0011-4
中图分类号
学科分类号
摘要
The neurorehabilitation program for cerebral palsy changes over time. During the first 2 years of life, an infant stimulation program with an emphasis on more than just improving motor deficits is emphasized. The importance of involvement of a knowledgeable therapist cannot be overemphasized. Realistic expectations must be articulated firmly. Rather then cautiously attempting to correct a dysfunction that cannot be corrected, the therapist should help the patient develop compensation techniques; the severity of the disability frequently militates against the development of “normal” motor control. Educating the parents about cerebral palsy, showing how positioning can be an effective way of helping the child be mobile, and encouraging parent-child interaction are aspects of an infant stimulation program. The therapist should serve as a coach to the parents, who implement much of the actual treatment on a daily basis at home.From 2 to 5 years of age, rapid growth occurs, and muscle tone will either develop or worsen—the latter leading not only to the development of contracture but also to a decrease in mobility. In developing a program to control this muscle tone, the most important question to be answered is, Can I improve the patient’s function and decrease the patient’s disability by altering muscle tone? It is not uncommon for the real problem preventing the patient from performing certain functions to be lack of motor control or lack of sensation and not the abnormal muscle tone [1].Between 5 and 10 years of age, the child begins to approach adult height. At this time, definitive orthopedic intervention can be considered; as already noted, contracture development occurs as a result of abnormal muscle tone in combination with growth.Finally, as the child approaches the teen years, issues of sitting and hygiene are important considerations, especially in the nonambulatory patient. The problem of pain secondary to spasticity or dystonia must be addressed.
引用
收藏
页码:97 / 107
页数:10
相关论文
共 97 条
[1]  
Landau WM(1974)Spasticity: the fable of a neurological demon and the emperor’s new therapy [editorial] Arch Neurol 31 217-219
[2]  
Nelson KB(1978)Epidemiology of cerebral palsy Adv Neurol 19 421-435
[3]  
Ellenberg IH(1967)Methods of rehabilitation in children with neuromuscular disorders Pediatr Clin North Am 14 1009-1017
[4]  
Weiss H(1984)The changing panorama of cerebral palsy in Sweden. IV. Epidemiological trends 1959–1978 Acta Pediatr Scand 73 433-440
[5]  
Betts HB(1986)Prevalence of and risk factors for cerebral palsy in a total population cohort of low-birthweight (<2000 g) infants Dev Med Child Neurol 28 559-568
[6]  
Hagberg B(1996)Quantifying the effects of interventions for movement disorders resulting from cerebral palsy J Child Neurol 11 S61-S70
[7]  
Hagberg G(1988)Identification of children with cerebral palsy unable to maintain a normal nutritional state Lancet 1 283-285
[8]  
Olow I(1986)Growth of severely impaired children: neurological versus nutritional factors Dev Med Child Neurol 28 729-733
[9]  
Stanley FJ(1985)Vocational predictions compared with present vocational status of 60 young adults with cerebral palsy Dev Med Child Neurol 27 775-784
[10]  
English DR(1996)Oral pharmacology for the movement disorders of cerebral palsy J Child Neurol 11 S13-S22